Abstract
Endothelium-derived relaxing factor (EDRF) was discovered by Furchgott and Zawadzki (1980), who observed that acetylcholine-induced relaxation of the isolated rabbit aorta was endothelium-dependent and that vascular smooth muscle directly responded to acetylcholine with slight contraction. The discovery brought us the marvelous idea that vascular endothelium influences not only the blood stream but also the smooth muscle cells, thus participating in the regulation of platelet aggregation and adhesion and of vascular tone. In 1988 EDRF was identified as nitric oxide (NO), a highly diffusible and short-lived free radical, synthesized by NO synthase from L-arginine (Palmer et al. 1988a). Specific inhibitors of NO synthase (NOS), introduced by Palmer et al. (1988b), enabled us to clarify the physiological roles of endogenous NO. This lipophilic gas molecule is now recognized to be a new intercellular messenger not only in the circulatory system but also in the central nervous and immune systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aisaka K, Gross SS, Griffith OW, & Levi R. 1989. N G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 160:881–886.
Angus JA, & Cocks TM. 1989. Endothelium-derived relaxing factor. Pharmacol Ther 41:303–351.
Ayata C, Ma J, Meng W, Huang P, & Moskowitz MA. 1996. L-NA-sensitive rCBF augmentation during vibrissal stimulation in type III nitric oxide synthase mutant mice. J Cereb Blood Flow Metab 16:539–541.
Baggia S, Perkins K, & Greenberg B. 1997. Endothelium-dependent relaxation is not unformly impaired in chronic heart failure. J Cardiovasc Pharmacol 29:389–396.
Bredt DS, Hwang PM, & Snyder SH. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768–770.
Cases A, Stulak JM, Katusic Z, Villa E, & Romero JC. 1997. Hemodynamic and renal effects of cross-linked hemoglobin infusion. Am J Physiol 272.R793–R799.
Chauhan A, More RS, Mullins PA, Taylor G, Petch C, & Schofield PM. 1996. Aging associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Car-diol 28:1796–1804.
Chu A, Lin CC, Chambers DE, Kuehl WD, Palmer RMJ, Moncada S, & Cobb FR. 1991. Effects of inhibition of nitric oxide formation on basal tone and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 87:1964–1968.
Dijkhorst O, Rabelink TJ, Boer P, & Koomans HA. 1997. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans. Hypertension 29:1192–1198.
Edvinsson L, Muculloch J, & Uddman R. 1981. Immunohistochemical localization and effect upon cat pial arteries in vivo and in situ. J Physiol 318:251–258.
Feletou M, & Vanhoutte PM. 1996. Endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol 23:1082–1090.
Furchgott RF. 1983. Role of endothelium in responses of vascular smooth muscle. Circ Res 53:557–513.
Furchgott RF. 1984. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 24:175–197.
Furchgott RF, & Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–316.
Gardiner SM, Compton AM, Bennett T, Palmer RMJ, & Moncada S. 1990. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15:486–492.
Gaw AJ, Wadsworth RM, & Humphrey PPA. 1990. Neurotransmission in the sheep middle cerebral artery: modulation of responses by 5-HT and haemolysate. J Cereb Blood Flow Metab 10:409–416.
Griffith TM, Edwards DH, Lewis MJ, Newby AC, & Henderson AH. 1984. The nature of endothelium-derived vascular relaxing factor. Nature 329:442–445.
Haynes WG, Noon JP, Walker BR, & Webb DJ. 1993. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 11:1375–1380.
Hibbs JB Jr, Taintor RR, & Vavrin Z. 1987. Macrophage cytotoxicity: role for L-arginine deiminase activity and imino nitrogen oxidation to nitrite. Science 235:473–416.
Hill C, Lateef AM, Engels K, Samsell L, & Baylis C. 1997. Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am J Physiol, 272:R1747–R1753.
Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, & Fishman MC. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242.
Kawasaki H, Takasaki T, Saito A, & Goto K. 1988. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335:164–167.
Klabunde RE, Ritger RC, & Helgren MC. 1991. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Eur J Pharmacol 199:51–59.
Larsson LI, Edvinsson L, Fahrenkrug J, Hakanson R., Owman C, Schaffalitzky-deMuckadell O, & Sundler F. 1976. Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res 113:400–404.
Leckstrom A, Ahlner J, Grundstrom N, & Axelsson KL. 1993. Involvement of nitric oxide and peptides in the inhibitory non-adrenergic, non-cholinergic (NANC) response in bovine mesenteric artery. Pharmacol Toxicol 72:194–198.
Lee JJ, Oimos L, & Vanhoutte PM. 1996. Recovery of endothelium-dependent relaxations four weeks after ischemia and progressive reperfusion in canine coronary arteries. Proc AssocAm Physician 108:362–367.
Lee TJ-F, Sarwinski SJ. 1991. Nitric oxidergic vasodilation in the porcine basilar artery. Blood Vessels 28:407–412.
Liu SF, Crawley DE, Rohde JAL, Evans TW, & Barnes PJ. 1992. Role of nitric oxide and guanosine 3’, 5’-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol 107:861–866.
Lockette W, Otsuka Y, & Carretero O. 1986. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8(Suppl):II6ĹŞ66.
Moncada S, Palmer RMJ, & Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142.
Montecot C, Borredon J, Seylaz J, & Pinard E. 1997. Nitric oxide of neuronal origin is involved in cerebral blood flow increase during seizures induced by kainate. J Cereb Blood Flow Metab 17:94–99.
Okamura T, & Toda N. 1994a. Nitric oxide (NO)-mediated, vasodilator nerve function and its susceptibility to calcium antagonists. J Auton Nerv Sys 49:S55–S58.
Okamura T, & Toda N. 1994b. Inhibition by calmodulin antagonists of the neurogenic relaxation in cerebral arteries. Eur J Pharmacol 256:79–83.
Okamura T, & Toda N. 1994c. Mechanism underlying nicotine-induced relaxation in dog saphenous arteries. Eur J Pharmacol 263:85–91.
Okamura T, Inoue S, & Toda N. 1989a. Action of atrial natriuretic peptide (ANP) on dog cerebral arteries: evidence that neurogenic relaxation is not mediated by release of ANP. Br J Pharmacol 97:1258–1264.
Okamura T, Minami Y, Toda N. 1989b. Endothelium-dependent and independent mechnisms of action of acetylcholine in monkey and dog isolated arteries. Pharmacology 35:279–288.
Okamura T, Ayajiki K, & Toda N. 1995. Basilar arterial constriction caused by intracisternal N G-nitro-L-arginine in anesthetized monkeys. Cardiovasc Res 30:663–667.
Okamura T, Ayajiki K, & Toda N. 1996. Neural mechanism of pressor action of nitric oxide synthase inhibition in anesthetized monkeys. Hypertension 28:341–346.
Palmer RMJ, Ashton DS, & Moncada S. 1988a. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664–666.
Palmer RMJ, Rees DD, Ashton DS, & Moncada S. 1988b. L-Arginine is the physiological precursor for the formation of nitric oxide in the endothelium-dependent relaxation. Biochem Biophys Res Commun 153:1251–1256.
Possas OS, & Lewis SJ. 1997. NO-containing factors mediate hindlimb vasodilation produced by superior laryngeal nerve stimulation. Am J Physiol 273:H234–H243.
Rees DD, Palmer RMJ, Hodson HF, & Moncada S. 1989a. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 96:418–424.
Rees DD, Palmer RMJ, & Moncada S. 1989b. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375–3378.
Rees DD, Schulz R, Hodson HF, Palmer RMJ, & Moncada S. 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746–752.
Rubanyi GM, Romero JC, & Vanhoutte PM. 1992. Flow-induced release of endotheliumderived relaxing factor. Am J Physiol 250:H1145–H1149.
Sessa WC, Barber CM, & Lynch KR. 1993. Mutation of N-myristoylation site converts endothelial nitric oxide synthase from a membrane to a cytosolic protein. Circ Res 72i921–924.
Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, & Takeshita A. 1996. The importance of the hyper-polarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28:703–711.
Toda N. 1975. Nicotine-induced relaxation in isolated canine cerebral arteries. J Pharmacol ExpTher 193:376–384.
Toda N. 1978. Heterogeneity in the relaxation of vascular smooth muscle. In: Vanhoutte PM, ed. Vasodilatation. Basel: Karger, pp 129–136.
Toda N. 1982. Relaxant responses to transmural stimulation and nicotine of dog and monkey cerebral arteries. Am J Physiol 243:H145–H153.
Toda N. 1988. Hemolysate inhibits cerebral artery relaxation. J Cereb Blood Flow Metab 8:46–53.
Toda N. 1993. Mediation by nitric oxide of neurally-induced human cerebral artery relaxation. Experientia 49:51–53.
Toda N. 1994. Nitroxidergic innervation in smooth muscle. In: Matsuo Y, Kasuya Y, Tuchiya M, & Nagao F, eds. Gastrointestinal Function; Regulation and Disturbances, Vol 12. Tokyo: Excerpta Medica, pp3–7.
Toda N. 1995. Nitric oxide and regulation of cerebral arterial tone. In: Vincent R, ed. Nitric Oxide in the Nervous System. New York: Academic Press, pp 207–225.
Toda N, & Okamura T. 1990a. Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarterial muscle. Biochem Biophys Res Commun 170:308–313.
Toda N, & Okamura T. 1990b. Mechanism underlying the response to vasodilator nerve stimulation in isolated dog and monkey cerebral arteries. Am J Physiol 259: H1511–H1517.
Toda N, & Okamura T. 1991. Suppression by N G-monomethyl-L-arginine of cerebroarteial responses to nonadrenergic, noncholinergic vasodilator nerve stimulation. J Cardiovasc Pharmacol 17 (Suppl 3:S234–S237.
Toda N, & Okamura T. 1992a. Regulation by nitroxidergic nerve of arterial tone. News Physiol Sci 7:148–152.
Toda N, & Okamura T. 1992b. Different susceptibility of vasodilator nerve, endothelium and smooth muscle functions to Ca++ antagonists in cerebral arteries. J Pharmacol Exp Ther 261:234–239.
Toda N, & Okamura T. 1992c. Mechanism of neurally induced monkey mesenteric artery relaxation and contraction. Hypertension 19:161–166.
Toda N, Minami Y, & Okamura T. 1990. Inhibitory effects of L-N G-nitro-arginine on the synthesis of EDRF and the cerebroarterial response to vasodilator nerve stimulation. Life Sci 47:345–351.
Toda N, Kawakami M, Yamazaki M, & Okamura T. 1991a. Comparison of endothelium-dependent responses of monkey cerebral and temporal arteries. Br J Pharmacol 102:805–810.
Toda N, Kitamura Y, & Okamura T. 1991b. New idea on the mechanism of hypertension: suppression of nitroxidergic vasodilator nerve function. J Vasc Med Biol 3:235–241.
Toda N, Yoshida K, & Okamura T. 1991c. Analysis of the potentiating action of N G-nitro L-arginine on the contraction of the dog temporal artery elicited by transmural stimulation of noradrenergic nerves. Naunyn Schmiedeberg’s Arch Pharmacol 343:221–224.
Toda N, Ayajiki K, & Okamura T. 1993a. Endothelial modulation of contractions caused by oxyhemoglobin and N G-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke 24: 584–1588.
Toda N, Ayajiki K, & Okamura T. 1993b. Neural mechanism underlying basilar arterial constriction by intracisternal L-NNA in anesthetized dogs. Am J Physiol 265:H103–H107.
Toda N, Kitamura Y, & Okamura T. 1993c. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 21:3–8.
Toda N, Kimura T, Yoshida K, Bredt DS, Snyder SH, Yoshida Y, & Okamura T. 1994. Human uterine arterial relaxation induced by nitroxidergic nerve stimulation. Am J Physiol 266:H1446–H1450.
Toda N, Uchiyama M, & Okamura T. 1995. Prejunctional modulation of nitroxidergic nerve function in canine cerebral arteries. Brain Res 700:213–218.
Toda N, Ayajiki K, & Okamura T. 1998. Effect of Ca2+/calmodulin-dependent protein ki-nase II inhibitors on the neurogenic cerebroarterial relaxation. Eur J Pharmacol 340:59–65.
Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, & Levi R. 1992. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 262:343–347.
Wanaka K, Matsuyama T, Yoneda S, Kimura K, Kamada T, Girgis S, Macintyre I, Emson P, & Tohyama M. 1986. Origins and distribution of calcitonin gene-related peptide-containing nerves in the wall of the cerebral arteries of the guinea pig with special reference to the coexistence with substance P. Brain Res 369:185–192.
Wang Y, Okamura T, & Toda N. 1993. Mechanisms of acetylcholine-induced relaxation in dog external and internal ophthalmic arteries. Exp Eye Res 57:275–281.
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, & Moncada S. 1994. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91:5212–5216.
Yoshida K, Okamura T, Kimura H, Bredt DS, Snyder SH, & Toda N. 1993. Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res 629:67–72.
Yoshida K, Okamura T, & Toda N. 1994. Histological and functional studies on the nitroxidergic nerve innervating monkey cerebral, mesenteric and temporal arteries. Jpn J Pharmacol 65:351–359.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Okamura, T., Toda, N. (2000). Nitric Oxide Derived from Perivascular Nerves and Endothelium. In: Kadowitz, P.J., McNamara, D.B. (eds) Nitric Oxide and the Regulation of the Peripheral Circulation. Nitric Oxide in Biology and Medicine, vol 1. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1326-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1326-0_6
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7095-9
Online ISBN: 978-1-4612-1326-0
eBook Packages: Springer Book Archive